Atnaujinkite slapukų nuostatas

El. knyga: China Rx: Exposing the Risks of America's Dependence on China for Medicine

4.15/5 (366 ratings by Goodreads)
  • Formatas: EPUB+DRM
  • Išleidimo metai: 17-Apr-2008
  • Leidėjas: Prometheus Books
  • Kalba: eng
  • ISBN-13: 9781633883826
Kitos knygos pagal šią temą:
  • Formatas: EPUB+DRM
  • Išleidimo metai: 17-Apr-2008
  • Leidėjas: Prometheus Books
  • Kalba: eng
  • ISBN-13: 9781633883826
Kitos knygos pagal šią temą:

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

Examines the implications for the quality and availability of prescription drugs for consumers that are manufactured in China.

"Millions of Americans are taking prescription drugs made in China and don't know it-- and pharmaceutical companies are not eager to tell them. This probing book examines the implications for the quality and availability of vital medicines for consumers"--Provided by publisher.

Gibson, an advisor and author of other books on healthcare, and Singh, an economic advisor, examine the implications of US reliance on China for prescription and over-the-counter drugs, how the US became dependent, the risks of dependence, and solutions to ensure self-sufficiency. They describe drugs made in China and sold in the US, including birth control pills, antibiotics, antidepressants, and drugs for HIV/AIDS, Alzheimer’s disease, bipolar disorder and schizophrenia, high blood pressure, cancer, and epilepsy, as well as those made with active ingredients from China; the role of the FDA; how economic and trade reasons led to the dependency, the methods China uses to control and manipulate the supply and price of ingredients, effects on American jobs, and safety aspects; the hidden cost of cheap drugs, such as safety, legal issues, and national security; and a plan to bring drugs back to the US, as well as how to find out where medicines are made. Annotation ©2018 Ringgold, Inc., Portland, OR (protoview.com)

Millions of Americans are taking prescription drugs made in China and don't know it--and pharmaceutical companies are not eager to tell them. This is a disturbing, well-researched wake-up call for improving the current system of drug supply and manufacturing.

Several decades ago, penicillin, vitamin C, and many other prescription and over-the-counter products were manufactured in the United States. But with the rise of globalization, antibiotics, antidepressants, birth control pills, blood pressure medicines, cancer drugs, among many others are made in China and sold in the United States.
     China's biggest impact on the US drug supply is making essential ingredients for thousands of medicines found in American homes and used in hospital intensive care units and operating rooms.
     The authors convincingly argue that there are at least two major problems with this scenario. First, it is inherently risky for the United States to become dependent on any one country as a source for vital medicines, especially given the uncertainties of geopolitics. For example, if an altercation in the South China Sea causes military personnel to be wounded, doctors may rely upon medicines with essential ingredients made by the adversary. Second, lapses in safety standards and quality control in Chinese manufacturing are a risk. Citing the concerns of FDA officials and insiders within the pharmaceutical industry, the authors document incidents of illness and death caused by contaminated medications that prompted reform.
     This probing book examines the implications of our reliance on China on the quality and availability of vital medicines.
Preface 9(4)
Acknowledgments 13(4)
PART I THE DIFFERENCE A COUNTRY MAKES
Chapter 1 "They Took My Heart Away"
17(10)
Chapter 2 What's in Your Medicine Cabinet?
27(14)
Chapter 3 Washington Wakes Up
41(12)
PART II PIVOT EAST: HOW IT HAPPENED
Chapter 4 "These Drugs Can Reach Anyone Including the President"
53(16)
Chapter 5 The Vitamin C and Penicillin Cartels
69(14)
Chapter 6 The China Trap
83(18)
Chapter 7 The Great American Sellout
101(16)
Chapter 8 Today's Gain, Tomorrow's Pain
117(20)
PART III THE HIDDEN COST OF CHEAP DRUGS
Chapter 9 Are Drugs from China Safe?
137(24)
Chapter 10 Made in China, Sue in America? Good Luck
161(12)
Chapter 11 The Perfect Crime
173(16)
Chapter 12 Where Does the Secretary of Defense Procure His Medicine?
189(16)
Chapter 13 China Bashing? Take a Look at This
205(16)
PART IV BRING IT HOME
Chapter 14 A Ten-Step Plan to Bring It Home
221(10)
Appendix: How to Find Out Where Your Medicines Are Made 231(4)
Notes 235(58)
Index 293
Rosemary Gibson has been credited with creating national movements for safer, more humane health care. Her first book, Wall of Silence, with co-author Janardan Prasad Singh, put a human face on medical mistakes, launching a national campaign to improve the safety of America's health care. Gibson worked with Bill Moyers on the PBS documentary On Our Own Terms. She is a recipient of the Lifetime Achievement Award from the American Academy of Hospice and Palliative Medicine and is also the founding editor of a narrative series in the Journal of the American Medical Association (JAMA) Internal Medicine. She is senior advisor at the Hastings Center and the 2014 winner of the highest honor from the American Medical Writers Association. She is also the author, with Janardan P. Singh, of three other books on health care. Janardan Prasad Singh is economic advisor at the World Bank. He designs strategies to strengthen economic development, health care, global trade, and national security for countries around the world. He has served as an advisor to prime ministers of India on national security affairs. Formerly, he was a member of the Board of Contributors of the Wall Street Journal.